A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease
Recruiting
Phase 1
Phase 2
Interventional Study
Coronary Heart Disease
Coronary Artery Disease
Atheroscleroses
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 50 – 75
- Sex
- Any
- Trial phase
- Phase 1/2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- Xia Liang · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn if Yiyang Huoluo Decoction (a custom Chinese herbal medicine) works safely and effectively to treat coronary heart disease with atherosclerosis in older adults. It also aims to find out how this herbal treatment may affect blood vessel health and repair at a cellular level.
The main questions it aims to answer are:
* Does adding Yiyang Huoluo Decoction…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
All of the following conditions must be met simultaneously for enrollment:
* ① Meet the diagnostic criteria for stable angina pectoris;
* ② Classified as Grade I to III according to the Canadian Cardiovascular Society (CCS) Angina Grading Scale;
* ③ Meet the diagnostic criteria…
Contacts